HealthAbbVie’s menstrual migraine treatment meets late-stage study goal

AbbVie said its migraine treatment met the goal of a late-stage study by reducing the number of migraine days associated with the menstrual period.

AbbViemigrainemenstrual health

RReuters★★☆☆☆2026-09-10 16:35Original